Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer
Clinical trial NCT00519324 · COMPLETED
Trial details
- NCT number
- NCT00519324
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-01-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.